临床试验/ISRCTN97798065

ISRCTN97798065已完成1 期

Phase I Trial, Quotient Code: QSC205947 [The full scientific title will be published within 30 months after the end of the trial]

Ventyx Biosciences, Inc.0 个研究点目标入组 20 人开始时间: 2023年2月23日最近更新: 2023年12月19日

适应症

试验速览

阶段: 1 期
状态: 已完成
发起方: Ventyx Biosciences, Inc.
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

性别: Male

入选标准

•Healthy human volunteer

排除标准

•The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

研究者

发起方

Ventyx Biosciences, Inc.

相似试验

[Trial of device that is not approved or cleared by the U.S. FDA]

NCT06762340[Redacted]

[Trial of device that is not approved or cleared by the U.S. FDA]

NCT04945941[Redacted]

[Trial of device that is not approved or cleared by the U.S. FDA]

NCT06733259[Redacted]

Clinical Investigation (Beta) of a New Developed Prosthetic Knee

NCT06748729Össur Iceland ehf11

[Trial of device that is not approved or cleared by the U.S. FDA]

NCT06422065[Redacted]